483
Center for Fertility and Reproductive Endocrinology UPPFDA 483 - Center for Fertility and Reproductive Endocrinology UPP - December 08, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Center for Fertility and Reproductive Endocrinology UPP in Pittsburgh, PA, revealed deficiencies in donor screening practices. The firm failed to adequately screen donors for communicable disease risk factors due to an incomplete donor risk assessment questionnaire. Additionally, an ineligible donor with risk factors for communicable disease agents was determined eligible and transferred to a recipient.
- Inspection Date
- December 8, 2021
- Product Type
- Biologics
Open in Dashboard
ID · 6a3fe83d-f04f-4ff0-bb01-c224fd427dc7